June 12, 2024

The Global Biological Seed Treatment Market is driven by increased need for sustainable farming practices

Biological seed treatment products contain beneficial microorganisms that help enhance plant health and provide resistance to crop diseases, thereby eliminating the need for chemical pesticides and fungicides. These seed treatment products contain plant growth-promoting rhizobacteria and fungi that colonize the plant’s root system upon germination and aid in nutrient uptake. Some common active ingredients in biological seed treatments include Trichoderma spp., Bacillus spp., Pseudomonas spp. that act as biocontrol agents to manage various soil-borne pathogens and parasites. With the rising environmental concerns about negative impacts of chemical crop protection agents, farmers are increasingly adopting biological options for seed treatment.

The global Biological Seed Treatment Market is estimated to be valued at US$ 1186.51 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Leading players are focusing on innovative formulations that combine multiple modes of action from different biological agents to provide enhanced and long-lasting protection against a broad spectrum of diseases. They are incorporating combinations of fungi, bacteria, and plant extracts in their proprietary seed treatment mixes. Furthermore, with regulations favoring reduced agrochemical residues, the demand for biological seed treatments is expected to continue growing as they help farmers comply with stringent MRL (maximum residue limits) set by regulatory agencies without compromising on yields.

Porter’s Analysis
Threat of new entrants: Low, as it requires substantial R&D investments and established distribution channels. Bargaining power of buyers: Moderate, as buyers have multiple options but demand is growing. Bargaining power of suppliers: Low, as raw materials are commonly available. Threat of new substitutes: Moderate, as other protection and enhancement solutions exist but demand is growing for biological seed treatment. Competitive rivalry: High, as the market has large number of global and regional players.

Key Takeaways

The Global Biological Seed Treatment Market Size is expected to witness high growth.

Regional analysis: The Asia Pacific region is expected to witness fastest growth in the biological seed treatment market owing to the increasing area under cultivation and awareness regarding organic farming in countries like India and China.

Key players operating in the biological seed treatment market are Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it